Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study

INTRODUCTION: Renin−angiotensin system (RAS) blockade using angiotensin-converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB) is first-line therapy for IgA nephropathy (IgAN). There is a paucity of information on the predictors and magnitude of response to this treatment. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagchi, Soumita, Mani, Kalaivani, Swamy, Anitha, Barwad, Adarsh, Singh, Geetika, Bhowmik, Dipankar, Agarwal, Sanjay Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207308/
https://www.ncbi.nlm.nih.gov/pubmed/34169207
http://dx.doi.org/10.1016/j.ekir.2021.02.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207308/
https://www.ncbi.nlm.nih.gov/pubmed/34169207
http://dx.doi.org/10.1016/j.ekir.2021.02.018

Ejemplares similares